Assessment of Crohn's disease activity and α1-antitrypsin in faeces
✍ Scribed by Arndt, B.; Schürmann, G.; Betzler, M.; Herfarth, CH.; Schmidt-Gayk, H.
- Book ID
- 122685247
- Publisher
- The Lancet
- Year
- 1992
- Tongue
- English
- Weight
- 184 KB
- Volume
- 340
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In a cohort study, the blood lipids of 35 children aged 6-8, 20 boys and 15 girls, and their parents were estimated to assess their relationship to energy expenditure measured using a minute-by-minute heart-rate method. Blood cholesterol and triglycerides were estimated using a Reflolron (Boehringer
Growth failure and malnutrition are major concerns in pediatric patients with frequent relapses of Crohn's disease (CD). In search of an early, noninvasive marker of relapse, we prospectively examined the relationship between levels of fecal al-antitrypsin (ctl-AT) in comparison with other known inf
Background: The Crohn's Disease Activity Index (CDAI) has become the gold standard for assessment of disease activity in CD. This study investigated the relationship between CDAI and the physicians' global assessment of disease activity (PGA) and whether different demographic and disease-related fac